Chanakya Nath Kundu Selected Research

Chanakya Nath Kundu Research Topics

Disease

38	Neoplasms (Cancer) 03/2024 - 04/2012
24	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2011
15	Mouth Neoplasms (Oral Cancer) 01/2024 - 11/2015
8	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2016
8	Colonic Neoplasms (Colon Cancer) 05/2018 - 01/2011
4	Colorectal Neoplasms (Colorectal Cancer) 07/2023 - 01/2011
3	Carcinogenesis 01/2023 - 01/2011
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2021 - 12/2014
2	Pain (Aches) 03/2024 - 01/2023
2	Hypoxia (Hypoxemia) 09/2023 - 01/2018
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2020 - 04/2019
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 01/2019
2	Neuralgia (Stump Neuralgia) 06/2019 - 10/2018
1	Asthenia 03/2024
1	Anorexia 03/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024
1	Cachexia 03/2024
1	Fatigue 03/2024
1	Fibrosis (Cirrhosis) 03/2024
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2024
1	Genomic Instability 11/2023
1	Gram-Negative Bacterial Infections 03/2023
1	Enterobacteriaceae Infections 03/2023
1	Cancer Pain 01/2023
1	Leukemia 09/2022
1	Dysbiosis 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Melanoma (Melanoma, Malignant) 12/2021
1	Inflammation (Inflammations) 07/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 10/2020
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 10/2018
1	Triple Negative Breast Neoplasms 10/2017

Drug/Important Bio-Agent (IBA)

22	Quinacrine (Mepacrine)IBA 01/2024 - 01/2012
10	CytokinesIBA 03/2024 - 01/2018
9	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2014
9	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2024 - 01/2016
8	ResveratrolIBA 01/2024 - 01/2011
8	Fluorouracil (Carac)FDA LinkGeneric 07/2023 - 01/2011
7	GoldIBA 01/2024 - 01/2018
7	SilverIBA 01/2020 - 08/2013
6	ChromatinIBA 01/2024 - 01/2021
6	CurcuminIBA 09/2023 - 09/2015
5	olaparibIBA 01/2024 - 10/2020
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023 - 01/2020
4	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 10/2020
4	SmokeIBA 10/2021 - 01/2014
3	Interleukin-6 (Interleukin 6)IBA 01/2024 - 01/2018
3	veliparibIBA 07/2023 - 01/2016
3	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2017 - 01/2017
3	CateninsIBA 01/2017 - 10/2016
2	talazoparibIBA 12/2022 - 01/2022
2	ADAM17 ProteinIBA 04/2019 - 01/2018
2	diphenyl (biphenyl)IBA 05/2018 - 04/2012
2	BromidesIBA 05/2018 - 04/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 01/2017
2	Antimalarials (Antimalarial Agents)IBA 09/2015 - 01/2012
1	rofecoxib (Vioxx)FDA Link 03/2024
1	Transforming Growth Factor-beta Type I ReceptorIBA 03/2024
1	Cadherins (E-Cadherin)IBA 03/2024
1	Estrogen ReceptorsIBA 01/2024
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2024
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2023
1	Adenosine Triphosphate (ATP)IBA 09/2023
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 09/2023
1	Cephalosporins (Cephalosporin Antibiotics)IBA 03/2023
1	beta-Lactamases (beta-Lactamase)IBA 03/2023
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Drug CarriersIBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	Anticarcinogenic AgentsIBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 12/2021
1	InterferonsIBA 12/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2021
1	NectinsIBA 11/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 08/2021
1	Serine Proteases (Serine Protease)IBA 07/2021
1	Angiotensin-Converting Enzyme 2IBA 07/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2021
1	IntegrinsIBA 01/2021
1	Histones (Histone)IBA 01/2021
1	GelatinIBA 09/2020
1	AntioxidantsIBA 10/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018
1	Neuroprotective AgentsIBA 10/2018
1	Antineoplastic Agents (Antineoplastics)IBA 10/2017

Therapy/Procedure

9	Therapeutics 03/2024 - 12/2014
5	Drug Therapy (Chemotherapy) 02/2024 - 01/2011
2	Pain Management 01/2023 - 10/2018
1	Immunotherapy 02/2024
1	Radiotherapy 01/2023
1	Injections 12/2021